These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7026259)

  • 21. Lack of effect of the alpha-adrenergic agonist clonidine on pulsatile luteinizing hormone secretion in a double blind study in men.
    Kaufman JM; Vermeulen A
    J Clin Endocrinol Metab; 1989 Jan; 68(1):219-22. PubMed ID: 2642486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonidine twice daily in hypertension. Effects of two dosage regimens on blood pressure, side-effects and plasma clonidine concentrations.
    Lilja M; Huikuri H; Jounela AJ; Juustila HJ; Paalzow G
    Acta Med Scand; 1983; 214(2):111-7. PubMed ID: 6353878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lofexidine and clonidine in moderate essential hypertension.
    Wilkins LH; Winternitz SR; Oparil S; Smith LR; Dustan HP
    Clin Pharmacol Ther; 1981 Dec; 30(6):752-07. PubMed ID: 7030578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative antihypertensive effects of guanabenz and clonidine.
    Walker BR; Hare LE; Deitch MW
    J Int Med Res; 1982; 10(1):6-14. PubMed ID: 7037502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypotensive action and side-effects of flutonidin in normal subjects. A double-blind controlled trial.
    Sala P; Chierichetti SM; Ferrari P
    Eur J Clin Pharmacol; 1979; 16(6):375-9. PubMed ID: 393519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic and pharmacodynamic studies of oral clonidine in normotensive subjects.
    Anavekar SN; Jarrott B; Toscano M; Louis WJ
    Eur J Clin Pharmacol; 1982; 23(1):1-5. PubMed ID: 7128667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative antihypertensive and endocrinologic effects of clonidine and prazosin in patients with essential hypertension.
    Hubbell FA; Weber MA; Drayer JI; Rose DE
    South Med J; 1984 Oct; 77(10):1264-8. PubMed ID: 6385278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of the combination of alinidine and other anti-anginal drugs on heart rate and blood pressure in healthy volunteers.
    Harron DW; Deering AH; Scott M; McMahon M; Shanks RG
    Br J Clin Pharmacol; 1989 Jan; 27(1):23-9. PubMed ID: 2495813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of indoramin, labetalol and alinidine on sympathetic function in normal man.
    Nicholls DP; McNeill J; O'Connor PC; Harron DW; Leahey WJ; Shanks RG
    Br J Clin Pharmacol; 1984 Aug; 18(2):215-21. PubMed ID: 6386022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crossover comparison of moxonidine and clonidine in mild to moderate hypertension.
    Plänitz V
    Eur J Clin Pharmacol; 1984; 27(2):147-52. PubMed ID: 6499895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naloxone inhibits the centrally-mediated hypotensive actions of BHT-933 (azepexole).
    Tackett RL; Laskey R
    Life Sci; 1987 Oct; 41(17):2063-7. PubMed ID: 2823037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paradoxical pressor effects of beta-blockers in standing elderly patients with mild hypertension: a beneficial side effect.
    Cleophas TJ; Grabowsky I; Niemeyer MG; Mäkel WM; van der Wall EE;
    Circulation; 2002 Apr; 105(14):1669-71. PubMed ID: 11940545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind comparison of transdermal clonidine and oral captopril in essential hypertension.
    McMahon FG; Jain AK; Vargas R; Fillingim J
    Clin Ther; 1990; 12(2):88-100. PubMed ID: 2191779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonidine and prazosin effects in hypernoradrenergic vasodilator-treated and beta-blocker-treated patients.
    Mitchell HC; Pettinger WA
    Clin Pharmacol Ther; 1981 Sep; 30(3):297-302. PubMed ID: 6115731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A clinical study on the prolonged antihypertensive effect of clonidine in a sustained-release capsule formulation.
    Martens V; Bentsen P; Hochrein H
    Pharmatherapeutica; 1980; 2(7):456-61. PubMed ID: 7208540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postprandial and orthostatic cardiovascular changes after acute stroke.
    Robinson TG; Potter JF
    Stroke; 1995 Oct; 26(10):1811-6. PubMed ID: 7570730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical pharmacology and pharmacokinetics of clonidine.
    Dollery CT; Davies DS; Draffan GH; Dargie HJ; Dean CR; Reid JL; Clare RA; Murray S
    Clin Pharmacol Ther; 1976 Jan; 19(1):11-7. PubMed ID: 1245090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic and analgesic profile after intrathecal clonidine in humans. A dose-response study.
    Filos KS; Goudas LC; Patroni O; Polyzou V
    Anesthesiology; 1994 Sep; 81(3):591-601; discussion 27A-28A. PubMed ID: 8092504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypotensive and postural effects of the gamma-aminobutyric acid agonist muscimol and of clonidine.
    Baum T; Becker FT
    J Cardiovasc Pharmacol; 1982; 4(2):165-9. PubMed ID: 6175796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Oral premedication with clonidine as an alternative in dental practice. The effects on the pain threshold, blood pressure and salivary flow].
    Fanini D; Poglio M; Marci MC; Iovinelli G; Antenucci F
    Minerva Stomatol; 1998 Sep; 47(9):453-64. PubMed ID: 9835755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.